Conversely, PI3K-C2α was found to rarely be mutated in breast cancer patients on publicly available datasets, but it was observed as lost at both the mRNA and protein levels in a large cohort of breast cancer patients [152]. Here, PIK3CG is linked to breast carcinoma.